PDS Biotech’s oncology pipeline leverages the Versamune® platform and Versamune® plus PDS01ADC in combination with proprietary tumor-specific proteins or peptides (antigens) in the development of targeted cancer immunotherapies. PDS Biotech’s infectious disease pipeline combines the Infectimune® platform technology with pathogen-specific antigens in the development of preventive infectious disease vaccines.


PDSB updated pipeline 20240403 

This website use cookies to facilitate the use of the website, improve its performance and security, personalize the proposed content.